- Home
- UTHR vs JBHT Comparison
UTHR vs JBHT Comparison
Compare UTHR & JBHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTHR
- JBHT
- Stock Information
- Founded
- UTHR 1996
- JBHT 1961
- Country
- UTHR United States
- JBHT United States
- Employees
- UTHR N/A
- JBHT N/A
- Industry
- UTHR Biotechnology: Pharmaceutical Preparations
- JBHT Trucking Freight/Courier Services
- Sector
- UTHR Health Care
- JBHT Industrials
- Exchange
- UTHR Nasdaq
- JBHT Nasdaq
- Market Cap
- UTHR 16.2B
- JBHT 18.1B
- IPO Year
- UTHR 1999
- JBHT N/A
- Fundamental
- Price
- UTHR $359.23
- JBHT $170.20
- Analyst Decision
- UTHR Buy
- JBHT Buy
- Analyst Count
- UTHR 14
- JBHT 18
- Target Price
- UTHR $370.86
- JBHT $189.33
- AVG Volume (30 Days)
- UTHR 313.6K
- JBHT 778.4K
- Earning Date
- UTHR 02-19-2025
- JBHT 01-16-2025
- Dividend Yield
- UTHR N/A
- JBHT 1.01%
- EPS Growth
- UTHR 25.10
- JBHT N/A
- EPS
- UTHR 22.72
- JBHT 5.50
- Revenue
- UTHR $2,756,200,000.00
- JBHT $12,244,556,000.00
- Revenue This Year
- UTHR $26.32
- JBHT N/A
- Revenue Next Year
- UTHR $10.37
- JBHT $5.61
- P/E Ratio
- UTHR $15.82
- JBHT $30.95
- Revenue Growth
- UTHR 25.04
- JBHT N/A
- 52 Week Low
- UTHR $208.62
- JBHT $153.12
- 52 Week High
- UTHR $417.82
- JBHT $219.51
- Technical
- Relative Strength Index (RSI)
- UTHR 43.90
- JBHT 25.24
- Support Level
- UTHR $358.82
- JBHT $180.00
- Resistance Level
- UTHR $383.00
- JBHT $185.29
- Average True Range (ATR)
- UTHR 9.97
- JBHT 3.89
- MACD
- UTHR -0.80
- JBHT -2.10
- Stochastic Oscillator
- UTHR 29.51
- JBHT 1.15
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
About JBHT J.B. Hunt Transport Services Inc.
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (48% of sales in 2023), dedicated trucking services that provide customer-specific fleet needs (28%), for-hire truckload (6%), heavy goods final-mile delivery (7%), and asset-light truck brokerage (11%).